Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GLUCARPIDASE
- Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma
- Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
- HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
- Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A
- Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
- Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL
- Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
- High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
- Voraxaze for Delayed Methotrexate Clearance
- Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
- Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
Clinical trials list
click for details